First Time Loading...
S

Santhera Pharmaceuticals Holding AG
SIX:SANN

Watchlist Manager
Santhera Pharmaceuticals Holding AG
SIX:SANN
Watchlist
Price: 9.32 CHF -0.53%
Updated: May 3, 2024

Santhera Pharmaceuticals Holding AG
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Santhera Pharmaceuticals Holding AG
Cash from Investing Activities Peer Comparison

Comparables:
ADCT
CRSP
BSLN
IDIA
KURN

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
S
Santhera Pharmaceuticals Holding AG
SIX:SANN
Cash from Investing Activities
-CHf3.9m
CAGR 3-Years
N/A
CAGR 5-Years
29%
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Cash from Investing Activities
-$3.2m
CAGR 3-Years
-4%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Cash from Investing Activities
$374.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Cash from Investing Activities
-CHf1m
CAGR 3-Years
69%
CAGR 5-Years
N/A
CAGR 10-Years
30%
Idorsia Ltd
SIX:IDIA
Cash from Investing Activities
CHf743.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Kuros Biosciences AG
SIX:KURN
Cash from Investing Activities
-CHf326k
CAGR 3-Years
-14%
CAGR 5-Years
13%
CAGR 10-Years
N/A

See Also

What is Santhera Pharmaceuticals Holding AG's Cash from Investing Activities?
Cash from Investing Activities
-3.9m CHF

Based on the financial report for Dec 31, 2022, Santhera Pharmaceuticals Holding AG's Cash from Investing Activities amounts to -3.9m CHF.

What is Santhera Pharmaceuticals Holding AG's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
29%